| A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants (NCT06103734) | Pfizer | 2025-09-15 |
| A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults (NCT07172321) | Pfizer | 2025-09-05 |
| A Study to Understand How the Body Processes [14C]PF-07104091 in Healthy Participants (NCT07127770) | Pfizer | 2025-08-28 |
| A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice. (NCT07152119) | Pfizer | 2025-08-27 |
| A Study to Learn if the Study Medicine Called Fluconazole Changes How the Other Body Processes the Study Medicine PF-07248144 (NCT07636018) | Pfizer | 2025-08-26 |
| BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies (NCT07160244) | Pfizer | 2025-08-25 |
| Atrial Fibrillation Data Linkage Non-Interventional Study (NCT05810727) | Pfizer | 2025-08-21 |
| A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors (NCT07090499) | Pfizer | 2025-08-20 |
| A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants (NCT06397144) | Pfizer | 2025-08-15 |
| A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants (NCT07130097) | Pfizer | 2025-08-14 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults (NCT06994897) | Pfizer | 2025-08-13 |
| A Study to Learn About a Vaccine Against E Coli in Healthy Adults (NCT07122986) | Pfizer | 2025-08-11 |
| STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON) (NCT07122661) | Pfizer | 2025-08-11 |
| A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women (NCT07153159) | Pfizer | 2025-08-07 |
| A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition (NCT07086664) | Pfizer | 2025-08-05 |
| A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. (NCT07062965) | Pfizer | 2025-08-05 |
| A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata (NCT07029711) | Pfizer | 2025-07-31 |
| This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1. (NCT06758401) | Pfizer | 2025-07-23 |
| A Study to Learn About How a New Pneumococcal Vaccine Works in Adults (NCT07086677) | Pfizer | 2025-07-22 |
| A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC) (NCT07086651) | Pfizer | 2025-07-21 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults. (NCT07514156) | Pfizer | 2025-07-15 |
| A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised (NCT07013474) | Pfizer | 2025-07-14 |
| A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer. (NCT06733337) | Pfizer | 2025-07-11 |
| A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese Adults (NCT07019909) | Pfizer | 2025-07-06 |
| A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out. (NCT06678555) | Pfizer | 2025-07-04 |
| A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database (NCT06962969) | Pfizer | 2025-06-30 |
| A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer (NCT06966453) | Pfizer | 2025-06-30 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy Adults (NCT06965465) | Pfizer | 2025-06-20 |
| A Study to Learn How the Study Medicine Called [14C]PF-07054894 is Processed by the Body (NCT07009353) | Pfizer | 2025-06-20 |
| A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) (NCT06991257) | Pfizer | 2025-06-19 |
| A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and Infant (NCT07023081) | Pfizer | 2025-06-15 |
| Korean Post Marketing Surveillance for ELREXFIO (Elranatamab). (NCT06581848) | Pfizer | 2025-06-05 |
| A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men (NCT07015918) | Pfizer | 2025-06-04 |
| SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDER (NCT06546800) | Pfizer | 2025-05-27 |
| A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma (NCT06977581) | Pfizer | 2025-05-20 |
| A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer (NCT04889495) | Pfizer | 2025-05-16 |
| A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine (NCT06995729) | Pfizer | 2025-05-16 |
| A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A. (NCT06703606) | Pfizer | 2025-05-13 |
| A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers (NCT06870487) | Pfizer | 2025-05-08 |
| Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer. (NCT06961331) | Pfizer | 2025-05-07 |
| Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer (NCT06952660) | Pfizer | 2025-05-07 |
| A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies (NCT06974734) | Pfizer | 2025-05-06 |
| A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors (NCT06799533) | Pfizer | 2025-05-01 |
| A Study to Learn How Different Tablets of the Study Medicine Mevrometostat Are Taken up Into the Blood in Healthy Adults (NCT06661694) | Pfizer | 2025-04-28 |
| Secondary Databased Post-marketing Surveillance Study of BNT162b2 (NCT06743334) | Pfizer | 2025-04-23 |
| A Study to Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 and How Much Money People Spend on Healthcare for COVID-19 (NCT06923137) | Pfizer | 2025-04-16 |
| A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose (NCT06866405) | Pfizer | 2025-04-16 |
| A Study to Learn About the Safety of TALZENNA for the Treatment of Breast Cancer (NCT06735742) | Pfizer | 2025-04-12 |
| A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight (NCT06973720) | Pfizer | 2025-04-07 |
| A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults (NCT06890416) | Pfizer | 2025-04-04 |
| A Study to Learn How a Tablet Compared With an IV Infusion of the Study Medicine Called Vepdegestrant is Taken up Into the Blood in Healthy Adults (NCT06911788) | Pfizer | 2025-04-03 |
| A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata (NCT06873945) | Pfizer | 2025-04-01 |
| A Study to Learn if the Study Medicine Called Carbamazepine Changes How the Body Processes PF-07220060 (NCT06897683) | Pfizer | 2025-03-21 |
| A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults (NCT06837259) | Pfizer | 2025-03-19 |
| Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B (NCT06634836) | Pfizer | 2025-03-17 |
| A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM (NCT06897202) | Pfizer | 2025-03-14 |
| Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity (NCT06910839) | Pfizer | 2025-03-13 |
| A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine (NCT06641466) | Pfizer | 2025-03-11 |
| A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes (NCT06924320) | Pfizer | 2025-03-06 |
| A Study to Learn More About the Study Medicine PF-07264660 in Healthy Chinese Adult Participants (NCT06712082) | Pfizer | 2025-02-24 |
| Effectiveness of ABRYSVO® Maternal Respiratory Syncytial Virus (RSV) Vaccine Against RSV in Infants in Western Pennsylvania (NCT06813872) | Pfizer | 2025-02-24 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the Body in Healthy Adults (NCT06821750) | Pfizer | 2025-02-11 |
| A Study to Learn About How Different Forms of Study Medicine PF-07248144 Are Taken Up Into the Blood in Healthy Adults (NCT07117799) | Pfizer | 2025-02-04 |
| A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings (NCT07200128) | Pfizer | 2025-02-03 |
| RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study (NCT06790420) | Pfizer | 2025-01-31 |
| A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India. (NCT06587035) | Pfizer | 2025-01-30 |
| A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies (NCT06698796) | Pfizer | 2025-01-22 |
| A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese Market (NCT07096024) | Pfizer | 2025-01-21 |
| A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML). (NCT06297161) | Pfizer | 2025-01-20 |
| A Study to Learn About How Well the Prevnar 20 Vaccine Works for Pneumonia in People Who Are 65 Years and Older (NCT06782282) | Pfizer | 2025-01-20 |
| Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context (NCT06487078) | Pfizer | 2025-01-20 |
| A Study to Learn More About the Study Medicine PF-07275315 in Healthy Chinese Adult Participants (NCT06675188) | Pfizer | 2025-01-06 |
| Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease (NCT06760637) | Pfizer | 2025-01-06 |
| A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults. (NCT06541678) | Pfizer | 2024-12-23 |
| A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults (NCT06705569) | Pfizer | 2024-12-20 |
| A Study to Learn if the Study Medicine Called Itraconazole and if Food Changes How the Body Processes the Other Study Medicine Called PF 07258669 in Older Adults or Healthy Adults (NCT06706869) | Pfizer | 2024-12-11 |
| A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene. (NCT06704724) | Pfizer | 2024-12-10 |
| A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity (NCT06717425) | Pfizer | 2024-12-09 |
| A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease (NCT06679140) | Pfizer | 2024-12-08 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-07941944 Are Tolerated in the Body of Healthy Adults. (NCT06920498) | Pfizer | 2024-12-03 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the Body in Healthy Adults (NCT06686797) | Pfizer | 2024-11-27 |
| A Study to Learn About the Safety of PREVENAR 20 Vaccine in Infants Aged Between Two to Six Months (NCT06622109) | Pfizer | 2024-11-25 |
| Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine (NCT06703190) | Pfizer | 2024-11-25 |
| A Study to Learn About if the Study Medicine Called Ibuzatrelvir Changes How the Body Process the Other Medicine Dabigatran Etexilate in Healthy Adults (NCT06693518) | Pfizer | 2024-11-22 |
| A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acne Vulgaris (NCT06671834) | Pfizer | 2024-11-22 |
| A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine (NCT06616194) | Pfizer | 2024-11-15 |
| A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer (NCT06580938) | Pfizer | 2024-11-11 |
| A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia. (NCT06476665) | Pfizer | 2024-11-07 |
| A Study of MET233 in Individuals With Obesity or Overweight (NCT07022977) | Pfizer | 2024-11-06 |
| FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients (NCT06564389) | Pfizer | 2024-11-05 |
| A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults (NCT06670170) | Pfizer | 2024-11-05 |
| A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe (NCT07072793) | Pfizer | 2024-10-31 |
| A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy Adults (NCT06646042) | Pfizer | 2024-10-28 |
| A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. (NCT06629779) | Pfizer | 2024-10-22 |
| A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). (NCT06551324) | Pfizer | 2024-10-21 |
| A Study to Learn How Different Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood in Healthy Adults (NCT06645938) | Pfizer | 2024-10-16 |
| Korean Post Marketing Surveillance for Comirnaty Injection (Bretovameran) (NCT06613984) | Pfizer | 2024-10-11 |
| Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey (NCT06680206) | Pfizer | 2024-10-10 |
| A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight (NCT06712836) | Pfizer | 2024-10-09 |
| A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea (NCT06593587) | Pfizer | 2024-10-07 |